Clal Insurance’s Varonis Systems VRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$81M Buy
1,706,500
+246,500
+17% +$11M 0.39% 59
2026
Q2
$61.3M Hold
1,460,000
– – 0.27% 66
2026
Q1
$31.3M Hold
1,460,000
– – 0.19% 78
2025
Q4
$47.9M Buy
1,460,000
+100,000
+7% +$4.2M 0.31% 63
2025
Q3
$78.2M Buy
1,360,000
+850,000
+167% +$47.2M 0.6% 42
2025
Q2
$25.9M Hold
510,000
– – 0.25% 70
2025
Q1
$20.6M Buy
510,000
+70,000
+16% +$3.01M 0.21% 63
2024
Q4
$19.5M Hold
440,000
– – 0.18% 63
2024
Q3
$24.9M Sell
440,000
-50,000
-10% -$2.63M 0.22% 60
2024
Q2
$23.5M Buy
490,000
+160,000
+48% +$7.09M 0.25% 59
2024
Q1
$15.6M Buy
+330,000
New +$15.7M 0.18% 70
2021
Q4
– Sell
-349,777
Closed -$21.3M – 245
2021
Q3
$21.3M Buy
349,777
+107,230
+44% +$6.72M 0.24% 93
2021
Q2
$14M Buy
242,547
+120,000
+98% +$6.25M 0.16% 101
2021
Q1
$6.29M Buy
+122,547
New +$7.27M 0.07% 119

Other funds holding VRNS

Clal Insurance's VRNS Position: Q3 2026 in Review

Clal Insurance increased its Varonis Systems (VRNS) stake by 17% in Q3 2026, buying an estimated $11M and bringing the position to 1,706,500 shares worth $81M. The position accounts for 0.39% of the portfolio, ranked #59.

Clal Insurance first reported a position in VRNS in Q1 2021 and has held it in 14 quarters since. 378 funds tracked by Wall St. Rank hold VRNS as of Q3 2026.

  • Clal Insurance held 1,706,500 shares of Varonis Systems worth $81M as of Q3 2026.
  • Clal Insurance bought 246,500 Varonis Systems shares in Q3 2026, an estimated $11M.
  • Varonis Systems made up 0.39% of Clal Insurance's portfolio in Q3 2026, its #59 holding.
  • Clal Insurance first reported a position in Varonis Systems in Q1 2021 and has held it in 14 quarters since.
  • 378 funds tracked by Wall St. Rank held Varonis Systems as of Q3 2026.

Based on Clal Insurance's 13F filing for Q3 2026, filed 12 Nov 2026.